CHI said operating revenues climbed to $4.2 billion in the third quarter of fiscal year 2017, up from $4.1 billion in the same period of the year prior. The increase was largely attributable to higher net patient service revenue, which grew 3.4 percent year over year to $3.8 billion in the third quarter of fiscal year 2017.
After factoring in expenses and one-time charges, CHI ended the most recent quarter with an operating loss. CHI reported an operating loss of $40.1 million in the third quarter of fiscal year 2017, compared to an operating loss of $81.6 million in the same period of the year prior.
Fueled by an increase in investment gains, CHI recorded a net surplus of $157.5 million in the third quarter of fiscal year 2017, compared to a net loss of $148.6 million in the same quarter of the year prior.
“While we are extremely pleased with the results in the third quarter, we have a lot of work to do to continue this performance-improvement effort,” Dean Swindle, CHI’s president for enterprise business lines and CFO, said in a news release.
Looking at the first nine months of fiscal year 2017, CHI reported an operating loss of $423.8 million on revenues of $12.2 billion. That’s compared to the first nine months of fiscal year 2016 when CHI recorded an operating loss of $188 million on revenues of $11.9 billion.
More articles on healthcare finance:
How CHS, Tenet, UHS, LifePoint and HCA fared in Q1
CMS further delays major bundled payment initiatives: 4 things to know
6 hospitals receive credit downgrades in past month
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
